Сourse patterns of postnatal cytomegalovirus infection in full-term infants. Cases in clinical practice
DOI: 10.32364/2618-8430-2023-6-2-206-214
A.S. Panchenko, E.V. Bem, G.N. Chumakova, I.V. Myznikova
St. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation
Cytomegalovirus infection (CMVI) is the most common viral infection in childhood. Congenital CMVI is quite well studied, always causes alertness of neonatologists, and has a diverse clinical picture after the birth of a child. Certain difficulties in diagnosis are noted in children who have postnatal CMVI. As a rule, the infection is asymptomatic or slightly symptomatic and has no special serious clinical consequences, unlike congenital CMVI, which causes hearing loss and central nervous system damage.
It is known that postnatal infection is dangerous for children with impaired immune system. This risk group consists of preterm infants, mainly with very low and extremely low body weight, and full-term infants with severe concomitant congenital and/or acquired pathology. The question of infecting ways for children with postnatal CMVI remains debatable. The article also discusses the various clinical manifestations of postnatal CMVI, which can occur according to the type of CMV-related sepsis-like syndrome, hepatitis, diarrhea, neutropenia.
The article highlights the importance of clear laboratory diagnostic criteria during establishing the diagnosis. There are always a lot of questions from the doctor regarding the prescription of specific treatment in CMVI and prevention methods of postnatal CMVI in full-term infants. This article also presents clinical case of postnatal CMVI in full-term infants with combined pathology receiving treatment in the conditions of the Perinatal center of St. Petersburg State Pediatric Medical University.
Keywords: postnatal cytomegalovirus infection, cytomegalovirus hepatitis, hearing loss, diagnosis, treatment, breast milk, neonates.
For citation: Panchenko A.S., Bem E.V., Chumakova G.N., Myznikova I.V. Сourse patterns of postnatal cytomegalovirus infection in full-term infants. Cases in clinical practice. Russian Journal of Woman and Child Health. 2023;6(2):206–214 (in Russ.). DOI: 10.32364/2618-8430-2023-6-2-206-214.
About the authors:
Alexandra S. Panchenko — Dr. Sc. (Med.), Associate Professor, Professor of the Department of Neonatology with Faculty of Neurology and Obstetrics-Gynecology, St. Petersburg State Pediatric Medical University; 2, Litovskaya str., St. Petersburg, 194044, Russian Federation; ORCID iD 0000-0003-2313-3941.
Elena V. Bem— C. Sc. (Med.), Assistant Professor of the Department of Neonatology with Faculty of Neurology and Obstetrics-Gynecology, St. Petersburg State Pediatric Medical University; 2, Litovskaya str., St. Petersburg, 194044, Russian Federation; ORCID iD 0009-0008-9337-5667.
Galina N. Chumakova — Dr. Sc. (Med.), Professor of the Department of Neonatology with Faculty of Neurology and Obstetrics-Gynecology, St. Petersburg State Pediatric Medical University; 2, Litovskaya str., St. Petersburg, 194044, Russian Federation; ORCID iD 0000-0001-5353-4610.
Irina V. Myznikova — Head of the Department of Neonatal Pathology, Perinatal Center of the St. Petersburg State Pediatric Medical University; 2, Litovskaya str., St. Petersburg, 194044, Russian Federation.
Contact information: Alexandra S. Panchenko, e-mail: sashawomen18@mail.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interests.
Received 17.02.2023.
Revised 14.03.2023.
Accepted 05.04.2023.
2. Luck S.E., Wieringa J.W., Blázquez-Gamero D. et al. Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management. Pediatr Infect Dis J. 2017;36(12):1205–1213. DOI: 10.1097/INF.0000000000001763.
3. Ssentongo P., Hehnly C., Birungi P. et al. Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021;4(8):e2120736. DOI: 10.1001/jamanetworkopen.2021.20736.
4. Dollard S.C., Grosse S.D., Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–363. DOI: 10.1002/rmv.544.
5. Gentile I., Zappulo E., Riccio M.P. et al. Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders. In Vivo. 2017;31(3):467–473. DOI: 10.21873/invivo.11085.
6. Kadambari S., Whittaker E., Lyall H. Postnatally acquired cytomegalovirus infection in extremely premature infants: how best to manage? Arch Dis Child Fetal Neonatal Ed. 2020;105(3):334–339. DOI: 10.1136/archdischild-2019-317650.
7. Resch B. How to Provide Breast Milk for the Preterm Infant and Avoid Symptomatic Cytomegalovirus Infection with Possible Long-Term Sequelae. Life (Basel). 2022;12(4):504. DOI: 10.3390/life12040504.
8. Nijman J., de Vries L.S., Koopman-Esseboom C. et al. Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings. Arch Dis Child Fetal Neonatal Ed. 2012;97(4):F259–F263. DOI: 10.1136/archdischild-2011-300405.
9. Hayashi S., Kimura H., Oshiro M. et al. Transmission of cytomegalovirus via breast milk in extremely premature infants. J Perinatol. 2011;31:440–445. DOI: 10.1038/jp.2010.150.
10. Yasuda A., Kimura H., Hayakawa M. et al. Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. Pediatrics. 2003:111:1333–1336. DOI: 10.1542/peds.111.6.1333.
11. Lee J.E., Han Y.S., Sung T.J. et al. Clinical presentation and transmission of postnatal cytomegalovirus infection in preterm infants. Front Pediatr. 2022;10:1022869. DOI: 10.3389/fped.2022.1022869.
12. Britt W. Cytomegalovirus. In: Infectious Diseases of the Fetus and Newborn Infant. Remington J.S., Klein J.O., eds. Elsevier; 2011:708–775. DOI: 10.1136/adc.2006.102566.
13. Lanzieri T.M., Dollard S.C., Josephson C.D. et al. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics. 2013;131(6):1937–1945. DOI: 10.1542/peds.2013-0076.
14. Wright C.J., Permar S.R. Preventing postnatal cytomegalovirus infection in the preterm infant: should it be done, can it be done, and at what cost? J Pediatr. 2015;166:795–798. DOI: 10.1016/j.jpeds.2014.12.062.
15. Kimberlin D.W., Brady M.T., Jackson M.A. et al. Red Book 2018: Report of the committee on infectious diseases. 31th ed. American Academy of Pediatrics; 2018.
16. Josephson C.D., Caliendo A.M., Easley K.A. et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study. JAMA Pediatr. 2014;168(11):1054–1062. DOI: 10.1001/jamapediatrics.2014.1360.
17. Mosca F., Pugni L., Barbi M., Binda S. Transmission of cytomegalovirus. Lancet. 2001;357(9270):1800. DOI: 10.1016/S0140-6736(00)04914-X.
18. Sue P.K., Salazar-Austin N.M., McDonald O.G. et al. Cytomegalovirus Enterocolitis in Immunocompetent Young Children: A Report of Two Cases and Review of the Literature. Pediatr Infect Dis J. 2016;35(5):573–576. DOI: 10.1097/INF.0000000000001080.
19. Pass R.F., August A.M., Dworsky M., Reynolds D.W. Cytomegalovirus infection in day-care center. N Engl J Med. 1982;307(8):477–479. DOI: 10.1056/NEJM198208193070804.
20. Roback J.D., Drew W.L., Laycock M.E. et al. CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion. 2003;43(3):314–321. DOI: 10.1046/j.1537-2995.2003.00312.x.
21. Badami К.G. CMV and transfusions, an old story that's not quite over yet. International Journal of Clinical Transfusion Medicine. 2014;2:7–19. DOI: 10.1046/j.1537-2995.2003.00312.x.
22. Ziemann M., Thiele T. Transfusion-transmitted CMV infection — current knowledge and future perspectives. Transfus Med. 2017;27(4):238–248. DOI: 10.1111/tme.12437.
23. Vamvakas E.C. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev. 2005;19(3):181–199. DOI: 10.1016/j.tmrv.2005.02.002.
24. Mabilangan C., Burton C., Nahirniak S. et al. Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs. Am J Transplant. 2020;20(12):3509–3519. DOI: 10.1111/ajt.16066.
25. Kotton C.N., Kumar D., Caliendo A.M. et al. The Third International Consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102(6):900–931. DOI: 10.1097/TP.0000000000002191.
26. Bianchi M., Orlando N., Valentini C.G. et al. Infectious complications in neonatal transfusion: Narrative review and personal contribution. Transfus Apher Sci. 2020;59(5):102951. DOI: 10.1016/j.transci.2020.102951.
27. Harmon C.M., Cooling L.L. Current strategies and future directions for the prevention of transfusion-transmitted cytomegalovirus. International Journal of Clinical Transfusion Medicine. 2017;5:49–59. DOI: 10.2147/IJCTM.S115669.
28. Osterholm E.A., Schleiss M.R. Impact of breast milk-acquired cytomegalovirus infection in premature infants: Pathogenesis, prevention, and clinical consequences? Rev Med Virol. 2020;30(6):1–11. DOI: 10.1002/rmv.2117.
29. Fouda G.G., Martinez D.R., Swamy G.K., Permar S.R. The Impact of IgG transplacental transfer on early life immunity. Immunohorizons. 2018;2(1):14–25. DOI: 10.4049/immunohorizons.1700057.
30. Yoo H.S., Sung S.I., Jung Y.J. et al. Prevention of cytomegalovirus transmission via breast milk in extremely low birth weight infants. Yonsei Med J. 2015;6:998–1006. DOI: 10.3349/ymj.2015.56.4.998.
31. Coclite Е., Di Natale С., Nigro G. Congenital and perinatal cytomegalovirus lung Infection. J Matern Fetal Neonatal Med. 2013;26(17):1671–1675. DOI: 10.3349/ymj.2015.56.4.998.
32. Шахгильдян В.И., Тишкевич О.А., Шипулина О.Ю. Клинико-лабораторная характеристика, патоморфологические особенности, диагностика и лечение цитомегаловирусной пневмонии. Инфекционные болезни. 2004:2(1):73–80. [Shakhgildyan V.I., Tishkevich O.A., Shipulina O.Yu. Clinical and laboratory characteristics, pathomorphological features, diagnosis and treatment of cytomegalovirus pneumonia. Infectious Diseases. 2004:2(1):73–80 (in Russ.)].
33. Kelly M.S., Benjamin D.K., Puopolo K.M. et al. Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary Dysplasia. JAMA Pediatr. 2015c;169(12):153785. DOI: 10.1001/jamapediatrics.2015.3785.
34. Ozkan T.B., Mistik R., Dikici B., Nazlioglu H.O. Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis. BMC Gastroenterol. 2007;7:9. DOI: 10.1186/1471-230X-7-9.
35. Min C.Y., Song J.Y., Jeong S.J. Characteristics and prognosis of hepatic cytomegalovirus infection in children: 10 years of experience at a university hospital in Korea. Korean J Pediatr. 2017;60(8):261–265. DOI: 10.3345/kjp.2017.60.8.261.
36. Shibata Y., Kitajima N., Kawada J. et al. Association of cytomegalovirus with infantile hepatitis. Microbiol Immunol. 2005;49(8):771–777. DOI: 10.1111/j.1348-0421.2005.tb03667.x.
37. Тezer H., Kanık Yüksek S., Gülhan B. et al. Cytomegalovirus hepatitis in 49 pediatric patients with normal immunity. Turk J Med Sci. 2016;46(6):1629–1633. DOI: 10.3906/sag-1507-161.
38. Ghidini B., Bellaiche M., Berrebi D. et al. Cytomegalovirus colitis in children with inflammatory bowel disease. Gut. 2006;55(4):582–583. DOI: 10.1136/gut.2005.086736.
39. Вайнштейн Н.П., Британишская Е.А., Митина Ю.Ю. и др. Роль цитомегаловирусной инфекции в поражении желудочно-кишечного тракта у новорожденных и детей раннего возраста. Неонатология: новости, мнения, обучение. 2018;6(4):70–85. DOI: 10.24411/2308-2402-2018-14008. [Vaynshteyn N.P., Britanishskaya E.A., Mitina Yu.Yu. et al. Cytomegalovirus enterocolitis in newborns and infants. Neonatology: News, Opinions, Training. 2018;6(4):70–85 (in Russ.). DOI: 10.24411/2308-2402-2018-14008.
40. Ekema G., Pedersini P., Milianti S. et al. Colonic stricture mimicking Hirschsprung's disease: A localized cytomegalovirus infection. J Pediatr Surg. 2006;41:850–852. DOI: 10.1016/j.jpedsurg.2005.12.029.
41. Kumar C., Luthra M. Cytomegalovirus as a Cause of Colonic Stricture-Simulating Hirschsprung's Disease. J Indian Assoc Pediatr Surg. 2018;23(2):103–105. DOI: 10.4103/jiaps.JIAPS_218_17.
42. Patel R.M., Shenvi N., Knezevic A. et al. Observational study of cytomegalovirus from breast milk and necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2019;105(3):259–265. DOI: 10.1136/archdischild-2018-316613.
43. Irizarry K., Honigbaum S., Demmler-Harrison G. et al. Successful treatment with oral valganciclovir of primary CMV enterocolitis in a congenitally infected infant. Fetal Pediatr Pathol. 2011;30(6):437–441. DOI: 10.3109/15513815.2011.587501.
44. Thiagarajah J.R., Kamin D.S., Acra S. et al. Advances in evaluation of chronic diarrhea in infants. Gastroenterology. 2018;154(8):2045–2059. DOI: 10.1053/j.gastro.2018.03.067.
45. Howard-Jones A.R., Cristerna-Tarrasa G.H., Khan R. et al. Severe Postnatal Cytomegalovirus Enterocolitis in Immunocompetent Term Infants Requiring Total Parenteral Nutrition. JPGN Rep. 2021;2(3):e110. DOI: 10.1097/PG9.0000000000000110.
46. Sheen J.M., Kuo H.C., Yu H.R. et al. Prolonged acquired neutropenia in children. Pediatr Blood Cancer. 2009;53(7):1284–1288. DOI: 10.1002/pbc.22247.
47. Hamprecht K., Maschmann J., Vochem M. et al. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 1998;357:513–518. DOI: 10.1016/S0140-6736(00)04043-5.
48. Carmona A.S., Kakkar F., Gantt S. Perinatal Cytomegalovirus Infection. Curr Treat Options Pediatr. 2022;8(4):395–411. DOI: 10.1007/s40746-022-00261-y.
49. Kadambari S., Atkinson C., Luck S. et al. Characterising variation in five genetic loci of cytomegalovirus during treatment for congenital infection. J Med Virol. 2017;89:502–207. DOI: 10.1002/jmv.24654.
50. Jim W.T., Chiu N.C., Ho C.S. et al. Outcome of Preterm Infants With Postnatal Cytomegalovirus Infection via Breast Milk: A Two-Year Prospective Follow-Up Study. Medicine (Baltimore). 2015;94(43):e1835. DOI: 10.1097/MD.0000000000001835.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
